Literature DB >> 16495281

Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi: comparison with CLSI broth microdilution method.

E López-Oviedo1, A I Aller, C Martín, C Castro, M Ramirez, J M Pemán, E Cantón, C Almeida, E Martín-Mazuelos.   

Abstract

The disk diffusion method was evaluated for determining posaconazole susceptibility against 78 strains of molds using two culture media in comparison with the CLSI (Clinical Laboratory Standards Institute) broth microdilution method (M38-A). A significant correlation between disk diffusion and microdilution methods was observed with both culture media.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495281      PMCID: PMC1426461          DOI: 10.1128/AAC.50.3.1108-1111.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

Review 1.  Uncommon opportunistic fungi: new nosocomial threats.

Authors:  A H Groll; T J Walsh
Journal:  Clin Microbiol Infect       Date:  2001       Impact factor: 8.067

2.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

Authors:  Kieren A Marr; Rachel A Carter; Fulvio Crippa; Anna Wald; Lawrence Corey
Journal:  Clin Infect Dis       Date:  2002-02-26       Impact factor: 9.079

3.  Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards.

Authors:  A Espinel-Ingroff; M Bartlett; V Chaturvedi; M Ghannoum; K C Hazen; M A Pfaller; M Rinaldi; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

4.  A comparative study of the disc diffusion method with the broth microdilution and Etest methods for voriconazole susceptibility testing of Aspergillus spp.

Authors:  M C Serrano; M Ramírez; D Morilla; A Valverde; M Chávez; A Espinel-Ingroff; R Claro; A Fernández; C Almeida; E Martín-Mazuelos
Journal:  J Antimicrob Chemother       Date:  2004-03-31       Impact factor: 5.790

Review 5.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.

Authors:  Ana Espinel-Ingroff; A Rezusta
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

7.  In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.

Authors:  K L Oakley; C B Moore; D W Denning
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

Review 8.  Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

Authors:  M M McNeil; S L Nash; R A Hajjeh; M A Phelan; L A Conn; B D Plikaytis; D W Warnock
Journal:  Clin Infect Dis       Date:  2001-07-30       Impact factor: 9.079

9.  In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida.

Authors:  A Cacciapuoti; D Loebenberg; E Corcoran; F Menzel; E L Moss; C Norris; M Michalski; K Raynor; J Halpern; C Mendrick; B Arnold; B Antonacci; R Parmegiani; T Yarosh-Tomaine; G H Miller; R S Hare
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

10.  In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs.

Authors:  M A Pfaller; S A Messer; L Boyken; R J Hollis; D J Diekema
Journal:  Diagn Microbiol Infect Dis       Date:  2003-04       Impact factor: 2.803

View more
  8 in total

1.  Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.

Authors:  A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  2006-08-30       Impact factor: 5.948

2.  Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.

Authors:  A Espinel-Ingroff; B Arthington-Skaggs; N Iqbal; D Ellis; M A Pfaller; S Messer; M Rinaldi; A Fothergill; D L Gibbs; A Wang
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

3.  Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of filamentous fungi with amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole.

Authors:  A Espinel-Ingroff; E Canton
Journal:  J Clin Microbiol       Date:  2008-03-12       Impact factor: 5.948

Review 4.  Antifungal peptides produced by actinomycetes and their biological activities against plant diseases.

Authors:  Dong Zhang; Yuele Lu; Hanchi Chen; Chutian Wu; Hui Zhang; Luyi Chen; Xiaolong Chen
Journal:  J Antibiot (Tokyo)       Date:  2020-03-02       Impact factor: 2.649

5.  Comparison between disk diffusion and microdilution methods for determining susceptibility of clinical fungal isolates to caspofungin.

Authors:  Maria Eleonora Milici; Carmelo Massimo Maida; Elisabetta Spreghini; Barbara Ravazzolo; Salvatore Oliveri; Giorgio Scalise; Francesco Barchiesi
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948

Review 6.  Methods for in vitro evaluating antimicrobial activity: A review.

Authors:  Mounyr Balouiri; Moulay Sadiki; Saad Koraichi Ibnsouda
Journal:  J Pharm Anal       Date:  2015-12-02

7.  Synthesis, Characterization and Bioassay of Novel Substituted 1-(3-(1,3-Thiazol-2-yl)phenyl)-5-oxopyrrolidines.

Authors:  Birutė Sapijanskaitė-Banevič; Božena Šovkovaja; Rita Vaickelionienė; Jūratė Šiugždaitė; Eglė Mickevičiūtė
Journal:  Molecules       Date:  2020-05-22       Impact factor: 4.411

Review 8.  From Ocean to Medicine: Pharmaceutical Applications of Metabolites from Marine Bacteria.

Authors:  José Diogo Santos; Inês Vitorino; Fernando Reyes; Francisca Vicente; Olga Maria Lage
Journal:  Antibiotics (Basel)       Date:  2020-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.